炎症性肠病患者肾脏及泌尿系统并发症的绝对风险与相对风险
在瑞典斯德哥尔摩2006-2018年1,682,795名就医者中,新发炎症性肠病与慢性肾病诊断(HR 1.24)、急性肾损伤(HR 1.97)和肾结石(HR 1.69)风险升高相关;炎症性肠病患者10年内慢性肾病事件绝对风险为11.8%,其中6.4%获慢性肾病诊断、7.9%达慢性肾病进展。
要点
- 新发炎症性肠病与慢性肾病诊断风险升高相关(HR 1.24,95%CI 1.10-1.40)。
- 炎症性肠病患者10年内慢性肾病事件绝对风险为11.8%,其中6.4%获诊断、7.9%达进展。
- 急性肾损伤(HR 1.97)和肾结石(HR 1.69)风险亦升高,克罗恩病与溃疡性结肠炎相似。
核心结论
- 超过10%的炎症性肠病患者在诊断后10年内发生慢性肾病,其中许多未通过诊断代码被识别。
- 炎症性肠病患者急性肾损伤和肾结石风险升高,这凸显了为炎症性肠病患者建立肾功能监测和转诊至肾内科/泌尿外科治疗的既定方案的必要性。
研究设计与样本
- 分析2006-2018年瑞典斯德哥尔摩1,682,795名就医者中新发炎症性肠病(作为时变暴露)与慢性肾病诊断、急性肾损伤、肾结石及估算肾小球滤过率临床相关下降(慢性肾病进展;肾衰竭或估算肾小球滤过率下降≥30%的复合终点)相对风险的关联。
- 在按性别、年龄和估算肾小球滤过率1:5匹配的炎症性肠病病例与随机对照平行匹配队列中,量化这些并发症的5年和10年绝对风险。
主要发现
- 中位随访9年期间,10,117名参与者新发炎症性肠病。
- 新发炎症性肠病与非炎症性肠病时期相比,慢性肾病诊断风险升高(HR 1.24,95%CI 1.10-1.40),慢性肾病进展风险升高(HR 1.11,95%CI 1.00-1.24)。
- 炎症性肠病患者10年内慢性肾病事件绝对风险为11.8%,其中6.4%获慢性肾病诊断,7.9%达慢性肾病进展。
- 急性肾损伤风险升高(HR 1.97,95%CI 1.70-2.29;10年绝对风险3.6%),肾结石风险升高(HR 1.69,95%CI 1.48-1.93;10年绝对风险5.6%)。
- 克罗恩病与溃疡性结肠炎中风险相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The burden of kidney and urological complications in patients with inflammatory bowel disease (IBD) remains poorly characterized. METHODS: We analyzed association between developing IBD (as a time-varying exposure) and relative risks of receiving diagnoses of chronic kidney disease (CKD), acute kidney injury (AKI), or kidney stones, and experiencing a clinically-relevant decline in estimated glomerular filtration rate (eGFR) (CKD progression; composite of kidney failure or an eGFR decline ≥30%) in 1,682,795 individuals seeking healthcare in Stockholm, Sweden, during 2006-2018. We quantified 5- and 10-year absolute risks of these complications in a parallel matched cohort of IBD cases and random controls matched (1:5) on sex, age, and eGFR. RESULTS: During median 9 years, 10,117 participants developed IBD. Incident IBD was associated with higher risks of kidney-related complications compared with non-IBD periods: hazard ratio (HR) (95% confidence interval) was 1.24 (1.10-1.40) for receiving a CKD diagnosis and 1.11 (1.00-1.24) for CKD progression. For absolute risks, 11.8% IBD cases had a CKD event within 10-year. Of these, 6.4% received a CKD diagnosis, and 7.9% reached CKD progression. The risks of AKI (HR 1.97 [1.70-2.29]; 10-year absolute risk 3.6%) and kidney stones (HR 1.69 [1.48-1.93]; 10-year absolute risk 5.6%) were also elevated. Risks were similar in Crohn's disease and ulcerative colitis. DISCUSSION: More than 10% of patients with IBD developed CKD within 10-year from diagnosis, with many not being identified through diagnostic codes. This, together with their elevated AKI and kidney stone risks, highlights the need of established protocols for kidney function monitoring and referral to nephrological/urological care for patients with IBD.
引用
- Yang Y, Ludvigsson JF, Olén O, et al. Absolute and Relative Risks of Kidney and Urological Complications in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2023. PMID: 37566886. doi:10.14309/ajg.0000000000002473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。